CEACAM5 and breast cancer: Previous studies have indicated that the serum levels of CEA and CA15-3 may vary across different molecular subtypes of breast cancer, and the preoperative levels of CEA and CA15-3 have been shown to significantly impact the prognosis of Chinese women with breast cancer (22, 23).